How to use a review article: Prophylactic endoscopic sclerotherapy for esophageal varices

Critical Care Medicine

Volumn 26, Issue 4, 1998, Pages 692-700

  Cook, Deborah J ^a,d,e   Levy, Mitchell M ^b   Heyland, Daren K ^c,d  

^a MCMASTER UNIVERSITY   (Canada)

^b BROWN UNIVERSITY   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^e ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Critical appraisal; Critical care; Esophageal varices; Evidence based medicine; Gastrointestinal bleeding; Meta analysis; Prevention; Review; Sclerotherapy; Systematic review

Indexed keywords

ALCOHOL LIVER CIRRHOSIS; ARTICLE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0031896293     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199804000-00017     Document Type: Article

References (65)

1. Pagliaro L, D'Amico G, Sorenson TIA, et al: Prevention of first bleeding in cirrhosis: A meta-analysis of randomized trials of non-surgical treatment. Ann Intern Med 1992; 117:59-70
2. Fardy JM, Laupacis A: A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994; 89:1938-1948
3. Bangert-Drowns RL: Misunderstanding meta-analysis. Evaluation and the Health Professional 1995; 18:304-314
4. Cook DJ, Sackett DL, Spitzer WO: Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 1995; 48:167-171
5. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:83-108
6. Antman EM, Lau J, Kupelnick B, et al: A comparison of results of meta-analyses of randomized trials and recommendations of clinical experts: Treatment for myocardial infarction. JAMA 1992; 268:240-248
7. Cook DJ, Mulrow C, Haynes RB: Systematic reviews: Synthesis of best evidence synthesis for clinical decisions. Ann Intern Med 1997; 126:376-380
8. Sacks HS, Berrier J, Reitman D, et al: Meta-analysis of randomized controlled trials. N Engl J Med 1987; 316: 450-455
9. Oxman AD, Guyatt GH: Validation of an index of the quality of review articles. J Clin Epidemiol 1991; 44:1271-1278
10. Jadad AR, McQuay HJ: Meta-analyses to evaluate analgesic interventions: A systematic qualitative review of their methodology. J Clin Epidemiol 1996; 49:235-243
11. Oxman AD, Cook DJ, Guyatt GH, et al: User's guides to the medical literature. VI. How to use an overview. JAMA 1994; 272:1367-1371
12. Chalmers TC, Berrier J, Sacks HS, et al: Meta-analysis of clinical trials as a scientific discipline. II. Replicate variability and comparison of studies that agree and disagree. Stat Med 1987; 6:733-744
13. Easterbrook PJ, Berlin JA, Gopalan R, et al: Publication bias in clinical research. Lancet 1991; 337:867-872
14. Dickersin K: The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263:1385-1389
15. Dickersin K, Min Y, Meinert CL: Factors influencing publication of research results. JAMA 1992; 267:374-378
16. Begg CB, Berlin JA: Publication bias: A problem in interpreting medical data. Journal of Research and Statistical Society 1988; 151:445-463
17. Cook DJ, Guyatt GH, Ryan G, et al: Should unpublished studies be included in meta-analyses? JAMA 1993; 269: 2749-2753
18. Grégoire G, Derderian F, LeLorier J: Selecting the language of the publications included in a meta-analysis: Is there a Tower of Babel bias? J Clin Epidemiol 1995; 48:159-163
19. Moher D, Fortin P, Jadad AR, et al: Assessing the quality of reports of non-English language randomized controlled trials: Implications for conduct and reporting of systematic reviews. Lancet 1995; 347:363-366
20. Moher D, Jadad AR, Nichol G, et al: Assessing the quality of randomized trials: An annotated bibliography of scales and checklists. Control Clin Trials 1995; 16:62-73
21. Jadad AR, Moore RA, Carrol D, et al: Assessing the quality of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12
22. Sacks HS, Chalmers TC, Smith H Jr: Randomized versus historical assignment in controlled clinical trials. N Engl J Med 1983; 309:1353-1361
23. Schulz KF, Chalmers I, Hayes RJ, et al: Empirical evidence of bias: Dimensions of methodologic quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412
24. Jaeschke RZ, Meade MO, Guyatt GH, et al: How to use diagnostic test articles in the ICU: Diagnosing weanability using f/Vt. Crit Care Med 1997; 25:1514-1521
25. Chalmers TC, Smith H, Blackburn B, et al: A method for assessing the quality of a randomized control trial. Control Clin Trials 1981; 2:31-49
26. Borzak S, Ridker PM: Discordance between meta-analysis and large-scale randomized, controlled trials. Ann Intern Med 1995; 123:873-877
27. Peto R: Why do we need systematic overviews of randomized trials? Stat Med 1987; 6:223-240
28. Yusuf S, Wittes J, Probstfiel J, et al: Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991; 266:93-98
29. Bhargava DK, Singh B, Dogra R, et al: Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents. Am J Gastroenterol 1992; 87:182-186
30. Irwig L, Tosteson ANA, Gastonis C, et al: Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994; 120:667-676
31. Smith K, Cook DJ, Guyatt GH, et al: Respiratory muscle training in chronic airflow limitation: A meta-analysis. Am Rev Respir Dis 1992; 145:533-539
32. Cook DJ, Hébert PC, Heyland DK, et al: How to use an article about therapy or prevention: Pneumonia prevention using subglottic secretion drainage. Crit Care Med 1997; 25:1502-1513
33. Oxman AD, Guyatt GH: A consumer's guide to subgroup analysis. Ann Intern Med 1992; 116:78-84
34. Yusuf S, Peto R, Lewis J, et al: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27:335-371
35. Pugh RNH, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for blooding oesophageal varices. Br J Surg 1973; 60:646-649
36. The Veterans Affairs Co-operative Variceal Sclerotherapy Group: Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. N Engl J Med 1991; 324:1779-1784
37. Paquet KJ: Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices: A prospective controlled randomized trial. Endoscopy 1982; 14:4-5
38. Potzi R, Bauer P, Reichel W, et al: Prophylactic endoscopie sclerotherapy of esophageal varices in liver cirrhosis: A multicentre prospective controlled randomised trial in Vienna. Gut 1989; 30:873-879
39. Piai G, Cipolleta L, Claar M, et al: Prophylactic sclerotherapy of high-risk esophageal varices: Results of a multicentric prospective controlled trial. Hepatology 1988; 8:1495-1500
40. Rockall TA, Logan RFA, Devlin HB, et al: Risk assessment after acute upper gastrointestinal hemorrhage. Gut 1996; 38:316-321
41. Chalmers TC, Lau J: Meta-analytic stimulus for changes in clinical trials. Stat Methods Med Res 1993; 2:161-172
42. Chalmers I, Haynes RB: Reporting, updating, and correcting systematic reviews of the effects of health care. In: Systematic Reviews. Chalmers I, Altman DG (Eds). London, BMJ Publishing Group, 1995, pp 86-95
43. Vandebroucke-Graus CMJE, Vandenbroucke JP: Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991; 338:859-862
44. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group: Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307:525-532
45. Kollef MH: The role of selective digestive tract decontamination on mortality and respiratory infections: A metaanalysis. Chest 1994; 105:1101-1108
46. Heyland DK, Cook DJ, Jaeschke R, et al: Selective decontamination of the digestive tract: An overview. Chest 1994; 105:1221-1229
47. Hurley JC: Prophylaxis with enterai antibiotics in ventilated patients: Selective decontamination or selective cross-infection? Antimicrob Agents Chemother 1995; 39:941-947
48. Sacks HS, Berrier J, Reitman D, et al: Meta-analysis of randomized controlled trials. N Engl J Med 1987; 316: 450-455
49. Sacks HS, Berrier J, Reitman D, et al: Meta-analysis of randomized controlled trials: An update of the quality and methodology. In: Medical Uses of Statistics. Second Edition. Bailar JC III, Mosteller F (Eds). Boston, NEJM Books, 1992, pp 427-442
50. Jadad A, Cook DJ, Browman G: When arbitrators disagree: Resolving discordant meta-analysis. Can Med Assoc J 1997; 156:1411-1416
51. Teo KK, Yusuf S, Collins R, et al: Effect of intravenous magnesium in suspected acute myocardial infarction: An overview of the randomized trials. BMJ 1991; 303:1499-1503
52. Yusuf S, Collins R, MacMahon S, et al: Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomized trials. Lancet 1988; i:1088-1092
53. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group: ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-685
54. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI): GISSI-3: Effects of lisinopril and transdermal glyceral trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343:1115-1122
55. Cappelleri JC, Ioannidis JPA, Schmid CH, et al: Large trials versus metaanalysis of smaller trials: How do their results compare? JAMA 1996; 276:1332-1338
56. LeLorier J, Gregoire G, Benhaddad A, et al: Discrepancies between metaanalyses and subsequent large randomized controlled trials. N Engl J Med 1997; 337:536-542
57. Advanced Ovarian Cancer Trialists Group: Chemotherapy in advanced ovarian cancer: An overview of randomized trials. BMJ 1991; 303:884-893
58. Stewart L, Parmar M: Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet 1993; 341:418-422
59. Jeng GT, Scott JR, Burmeister LF: A comparison of meta-analytic results using literature versus individual patient data: Paternal cell immunization for recurrent miscarriage. JAMA 1995; 274:830-836
60. Chalmers I: The Cochrane Collaboration: Preparing, maintaining and disseminating systematic reviews of the effects of health care. In: Doing more good than harm: The evaluation of health care interventions. Warren KS, Mosteller F (Eds). Ann N Y Acad Sci 1993; 703:153-163
61. Cochrane Collaboration: Cochrane Library, London. BMJ Publishing Group, electronic quarterly serial publication
62. Meade MO, Richardson WS: Selecting and appraising studies for a systematic review. Ann Intern Med 1997; 127: 531-537
63. McQuay HF, Moore RA: Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126:712-720
64. Badgett RG, O'Keefe M, Henderson M: Using systematic reviews in clinical education. Ann Intern Med 1997; 126:886-891
65. Bero LA, Jadad AR: How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med 1997; 127:37-42